Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment-Reference-Cited by-同舟云学术

Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment

Published:2010-03-17 Issue:7 Volume:89 Page:681-689
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Moon Joon Ho,Kim Shi Nae,Kang Byung Woog,Chae Yee Soo,Kim Jong Gwang,Baek Jin Ho,Park Jae Hoo,Song Moo Kon,Chung Joo Seop,Won Jong Ho,Lee Sang Min,Joo Young Don,Kim Yeo Kyeoung,Kim Hyeong Joon,Jo Deog Yeon,Sohn Sang Kyun

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-010-0921-5.pdf

Reference15 articles.

1. Sloand EM (2008) Myelodysplastic syndromes: introduction. Semin Hematol 45:1–2

2. Valent P, Horny HP, Bennett JM et al (2007) Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res 31:727–736

3. Greenberg P, Cox C, LeBeau MM et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079–2088

4. Alessandrino EP, Della Porta MG, Bacigalupo A et al (2008) WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Blood 112:895–902

5. Malcovati L, Germing U, Kuendgen A et al (2007) Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 25:3503–3510

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic-modifying agents: the potential game changers in the treatment of hematologic malignancies;Critical Reviews in Oncology/Hematology;2024-09

2. Real-World Outcome and Prognostic Factors in MDS Patients Treated with Azacitidine—A Retrospective Analysis;Cancers;2024-03-29

3. Natural killer cell epigenetic reprogramming in tumors and potential for cancer immunotherapy;Epigenomics;2023-02

4. Mutations in genes affecting DNA methylation enhances responses to decitabine in patients with myelodysplastic syndrome;The Korean Journal of Internal Medicine;2021-03-01

5. Prognostic impact of peripheral blood Wilms’ tumour 1 mRNA expression levels in response to azacytidine in MDS: A single-centre analysis;Leukemia Research Reports;2021